In vivo evaluation of platelet activation by different cellulosic membranes

Artificial Organs

Volumn 21, Issue 4, 1997, Pages 330-334

  Cases, Aleix ^a   Reverter, Joan Carles ^a   Escolar, Gines ^a   Sanz, Cristina ^a   Sorribes, Josep ^a   Ordinas, Antoni ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Cellulosic membranes; Hemodialysis; P selectin; Platelet activation; Polysulfone

Indexed keywords

BIOCOMPATIBILITY; CELLULOSE; CHEMICAL ACTIVATION; HEMODIALYZERS; MEMBRANES; MONOCLONAL ANTIBODIES; PLATELETS;

CELLULOSE ACETATES; CELLULOSE TRIACETATE; CELLULOSIC MEMBRANE; CUPROPHAN; HAEMODIALYSIS; IN-VIVO; P-SELECTIN; PLATELET ACTIVATION; POLYSULPHONE; VIVO EVALUATION;

DIALYSIS;

CELLULOSE; POLYSULFONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

EID: 0030964414     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1997.tb00371.x     Document Type: Article

References (21)

1. Gordge MP, Neild GH. Platelet function in uremia, Platelets 1991;2:115-23.
2. Schulman G, Hakim RM. Recent advances in the biocompatibility of hemodialysis membranes. Nephrol Dial Transplant 1991;6(Suppl 2):10-3.
3. Sreedhara R, Itagaki I, Lynn B, Hakim RM. Defective platelet aggregation in uremia is transiently worsened by hemodialysis. Am J Kidney Dis 1995;25:555-63.
4. Levin RD, Kwann HC, Ivanovich P. Changes in platelet function during hemodialysis. J Lab Clin Med 1978;92:779-86.
5. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
6. Schmitt GW, Moake JL, Rudy CK, Vicks SL, Hamburger RJ. Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design. Am J Med 1987;83:411-8.
7. Flakenhagen D, Brown GS. Clinical evaluation of three haemodialyzers containing PMMA membranes of different surface area, with special attention to thrombogenicity. Nephrol Dial Transplant 1991;6(Suppl 2):43-8.
8. Green D, Santhanam S, Krumlovsky FA, del Greco F. Elevated β-thromboglobulin in patients with chronic renal failure effect of hemodialysis. J Lab Clin Med 1980;95:679-85.
9. Gawaz P, Ward RD. Effects of hemodialysis on platelet-derived thrombospondin. Kidney Int 1991;40:257-65.
10. McEver RP. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells 1990;16:73-3.
11. Reverter JC, Escolar G, Sanz C, Cases A, Villamor N, Niewenhuis HK, Lopez J, Ordinas A. Platelet activation during hemodialysis measured through exposure of P-selectin. Analysis by flow cytometry and ultrastructural techniques. J Lab Clin Med 1994;124:79-85.
12. Windus DW, Atkinson R, Santoro S. The effects of hemodialysis on platelet activation with new and reprocessed regenerated cellulose dialyzers. Am J Kidney Dis 1996;27:387-93.
13. Deguchi N, Ohigashi T, Tazaki H, Handa M, Ikeda I. Hemodialysis and platelet activation. Nephrol Dial Transplant 1991:6(Suppl 2):40-2.
14. Hakim RM, Schafer AI. Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med 1985;78:575-80.
15. Sreeharan N, Crow MJ, Salter MCP, Donaldson DR, Rajah SM, Davison AM. Membrane effect on platelet function during hemodialysis: A comparison of Cuprophane and polycarbonate. Artif Organs 1982;6:324-7.
16. Sultan Y, London G, Glodfarb B, Toulon P, Marchais SJ. Activation of platelets, coagulation and fibrinolysis in patients on long-term hemodialysis: Influence of Cuprophan and polyacrylonitrile membranes. Nephrol Dial transplant 1990;5:362-8.
17. Evans RC, Homes CJ. In vitro study of the transfer of cytokine-inducing substances across selected high-flux membranes. Blood Purif 1991;9:92-101.
18. Schultze CS, Hollman S, Sinah P. Formation of thrombin, antithrombin III complex using polyamide and Hemophan filters. Int J Artif Organs 1992;15:35-70.
19. Tassies D, Reverter JC, Cases A, Escolar G, Villamor N, Lopez-Pedret J, Castillo R, Ordinas A. Reticulated platelets in uremic patients: Effect of hemodialysis and continuous peritoneal dialysis. Am J Hematol 1995;50:161-6.
20. Hemmedinger S, Newman MR, Beretz A, Klein-Soyer C, Cazenave JP, Rich A, Scholm D, Jahn H. Mitogenic activity on human arterial smooth muscle cells is increased in the plasma of patients undergoing hemodialysis with Cuprophane. Nephron 1989;53:147-51.
21. Numano F, Kishi Y, Ashikaga T, Hata A, Makita T, Watanabe R. What effect does controlling platelets have on atherosclerosis? Ann NY Acad Sci 1995;748:383-93.